{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:21:51Z","timestamp":1790216511191,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T00:00:00Z","timestamp":1245196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p>Identification of tumor\u2010derived proteins in the circulation may allow for early detection of cancer and evaluation of therapeutic responses. To identify circulating tumor\u2010derived proteins, mice were immunized with concentrated culture medium conditioned by human breast cancer cells. Antibodies generated by hybridomas were screened against conditioned media from both normal epithelial cells and tumor cells. Antibody selectively reacting with tumor cell\u2013conditioned media was further characterized. This led to the development of a monoclonal antibody (Alper\u2010p280) that reacts with a newly identified 280\u2010kDa secreted variant of human filamin\u2010A. Circulating filamin\u2010A was detected in patient plasma samples using Alper\u2010p280 in an ELISA assay. Human plasma samples from 134 patients with brain, breast, or ovarian cancer, 15 patients with active arthritis, and 76 healthy controls were analyzed. Filamin\u2010A protein levels in human cell lines and tissues were analyzed by western blotting, immunohistochemistry, and electron and confocal microscopy. Circulating filamin\u2010A was detected in the plasma of 109 of 143 patients with breast cancer and primary brain tumors. Plasma levels of filamin\u2010A showed 89.5% sensitivity (95% confidence interval [CI]\u00a0=\u00a00.67% to 0.99%) and 97.8% specificity (95% CI\u00a0=\u00a00.88% to 0.99%) for glioblastoma at a cut\u2010off of 21.0\u00a0ng\/mL. Plasma levels of filamin\u2010A (&gt;36.0\u00a0ng\/mL) had 96.7% sensitivity (95% CI\u00a0=\u00a00.80% to 0.99%) and 67.8% specificity (95%\u00a0CI\u00a0=\u00a00.54% to 0.79%) for metastatic breast cancer. Filamin\u2010A levels were increased in malignant breast or brain tissues, but not in normal control tissues. Filamin\u2010A localized to lysosomes in MDA.MB.231 breast cancer cells, but not in normal human mammary epithelial cells, suggesting that filamin\u2010A may undergo cancer\u2010specific processing. Plasma filamin\u2010A appears to be a specific and sensitive marker for patients with high\u2010grade astrocytoma or metastatic breast cancer. Additional novel cancer biomarkers have been identified and are being developed alongside Alper\u2010p280 for use in diagnosis of breast carcinoma and high\u2010grade astrocytoma, and for use in the evaluation of therapeutic responses. (<jats:italic>Cancer Sci<\/jats:italic> 2009; 100: 1748\u20131756)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2009.01244.x","type":"journal-article","created":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T07:20:58Z","timestamp":1245223258000},"page":"1748-1756","source":"Crossref","is-referenced-by-count":45,"title":["Novel anti\u2010filamin\u2010A antibody detects a secreted variant of filamin\u2010A in plasma from patients with breast carcinoma and high\u2010grade astrocytoma"],"prefix":"10.1111","volume":"100","author":[{"given":"\u00d6zge","family":"Alper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Stetler\u2010Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay N.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang W.","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"\u00d6zdemirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mones","family":"Abu\u2010Asab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhe","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Bergmann\u2010Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne E.","family":"Criss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Seyda","family":"Karaveli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela","family":"Goldbach\u2010Mansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Stromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01105077"},{"key":"e_1_2_6_3_2","first-page":"1815","article-title":"Cathepsins B, H, and L and their inhibitors stefin A and cytostatin C in sera of melanoma patients","volume":"3","author":"Kos J","year":"1997","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/273545a0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0904"},{"key":"e_1_2_6_6_2","first-page":"591","article-title":"The presence of c\u2010erbB\u20102 gene product\u2010related protein in culture medium conditioned by breast cancer cell line SK\u2010BR\u20103","volume":"12","author":"Alper \u00d6","year":"1990","journal-title":"Cell Growth Differ"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(03)00026-2"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1373\/49.10.1579","article-title":"Potential clinical utility of serum HER\u20102\/neu oncoprotein concentrations in patients with breast cancer","volume":"49","author":"Carney WP","year":"2003","journal-title":"Cancer Clin Chem"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20387"},{"key":"e_1_2_6_10_2","first-page":"163","article-title":"Serum HER\u20102 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients","volume":"50","author":"Pichon MF","year":"2004","journal-title":"Clin Lab"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-092461-8.50009-5"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ncb1104-1034","article-title":"The many faces of filamin: a versatile molecular scaffold for cell motility and signaling","volume":"6","author":"Feng Y","year":"2004","journal-title":"Nat Cell Biol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.139.7.1719"},{"key":"e_1_2_6_15_2","first-page":"761","article-title":"Fibroblasts capture cathepsin D secreted by breast cancer cells: possible role in the regulation of the invasive process","volume":"20","author":"Heylen N","year":"2002","journal-title":"Int J Oncol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-23-08736.2000"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.5.2620"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.5.2122"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.154.7.3461","article-title":"Direct interaction of filamin (ABD) with the \u03b2\u20102 integrin subunit CD18","volume":"154","author":"Sharma CP","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1201-1060"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008422200"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/35052082"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.5.1092"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30376"},{"key":"e_1_2_6_25_2","first-page":"2645","article-title":"Prostate\u2010specific membrane antigen association with filamin A modulates its internalization and NAALDase activity","volume":"63","author":"Anilkumar G","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23016"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2419"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1021\/pr050455t"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2009.01244.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2009.01244.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:16:54Z","timestamp":1697235414000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2009.01244.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1349-7006.2009.01244.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01244.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,11]]}}}